Guidance on improving the quality of cell counting results to increase confidence amongst the inherent challenges when working with live cells.
Image cytometry and how it compares to other methods. Improve the quality of cell counting results to increase confidence in processes and workflows.
Exploration of candidate genes responsible for esophageal squamous cell carcinoma (ESCC) pathogenesis may provide insight into the underlying signaling pathways to uncover novel therapeutic targets.
The ATR-CHK1 pathway plays a critical role as a replication checkpoint and is a promising target for emerging therapies.
“Biological variation” is an easy explanation to reach for when repeated measurements don’t match up very well. It is vague enough to excuse inconsistency in nearly any biological experiment, and in many cases, it is difficult to disprove.
The development of targeted molecular therapies is an increasingly popular approach to combat and overcome the limitations of conventional treatments.
A fundamental understanding of the molecular mechanisms responsible for the development and progression of RCC will be pivotal in developing next-generation treatment protocols to improve patient outcomes.
Because there is no certified reference material to determine cell concentration, ISO cell counting standards are a valuable tool for evaluating and selecting fit-for-purpose cell counting methods.
From Cell-based Discovery and Development to High-Throughput Manufacturing. Rapid, Compliant, and Scalable Cell Counting Solutions with 21 CFR Part 11 compliance.
All of our systems will take images and analyze the sample in less than a minute - with most systems completing in less than 30 seconds! Our systems can image and analyze cells as small as 0.5 microns up to as large as 300 microns in size!